Attributes of pharmacy's educational activities according to good pharmacy practice standards from the perspective of patients with diabetes
Abstract
According to the Good Pharmaceutical Practice (GPP) Standards of Quality of Pharmacy Services, pharmacists should participate in preventive measures to improve the health of the population and prevent disease. The problem of diabetes is becoming increasingly relevant due to its prevalence and a significant number of undiagnosed cases. Patients with diabetes are frequent visitors to pharmacies and have specific needs for treatment.
The purpose of the study was to determine the attributes of pharmaceutical educational activities in pharmacies according to the standards of GPP from the perspective of patients with diabetes, as well as to compare the obtained results with similar ones in other countries.
The objects of the study were information sources regarding the involvement of pharmacists in the strategy of preventing diabetes in other countries, using literature review and analytical methods. To study the perspective of patients with diabetes, a semi-structured in-depth interview of patients with diabetes who use insulin therapy was applied.
Based on research using the semi-structured in-depth interview method, attributes of educational activities were identified in providing pharmaceutical care to patients with diabetes according to GPP standards: identifying individuals with risk factor of diabetes and people with undiagnosed diabetes; group training of diabetes patients in self-management control; and recommendations flu vaccination in the pre-epidemic period. The availability of diabetes risk factor detection and blood glucose testing in pharmacies contributes to early diagnosis and motivates patients to change their lifestyles. Training people with diabetes by qualified specialists are important for diabetes patients. The organasing of the «diabetes self management school» in pharmacies will increase the accessibility of training for diabetes patients and at the same time enhance the role of pharmacists in clinical practice and the social image of the pharmacy. To promote flu vaccination among patients with diabetes, pharmacists should be actively involved in providing information and promoting vaccination.
The identified attributes of educational activities in providing pharmaceutical care according to GPP standards have already been implemented in many countries of the world and have demonstrated their high efficiency for the health care system.
References
Joint FIP/WHO Guidelines on Good Pharmacy Practice: Standards for Quality of Pharmacy Services. ‒ 2011. ‒ URL: http://apps.who.int/medicinedocs/en
Nemchenko A. S., Panfylova A. L. Teoryia y praktyka orhanyzatsyy farmatsevtycheskoi pomoshchy naselenyiu v uslovyiakh medytsynskoho strakhovanyia // Mezhdunar. med. zhurn. – 2010. – № 2. – S. 101‒106.
Resolution WHO 24 May 2021. Reducing the burden of noncommunicable diseases through strengthening prevention and control of diabetes. ‒ URL: https://apps.who.int/gb/ebwha/pdf_files/WHA74/A74_ACONF5-en.pdf
International Diabetes Federation. IDF Diabetes Atlas, 10th edn. ‒ Brussels, Belgium, 2021. – URL: https://www.diabetesatlas.org
Tracey M. L., Gilmartin M., O'Neill K. et al. Epidemiology of diabetes and complications among adults in the Republic of Ireland 1998‒2015: a systematic review and meta-analysis // BMC Public Health. – 2016. – N 16 (1). – P. 132. https://doi.org/10.1186/s12889-016-2818-2
NCD Risk Factor Collaboration (NCD-RisC). Worldwide trends in diabetes since 1980: a pooled analysis of 751 population-based studies with 4·4 million participant // Lancet. ‒ 2016. – N 387. – Р. 1513‒1530. https://doi.org/10.1016/S0140-6736(16)00618-8
Rege N. K., Liu M., Yang Y. et al. Evolution of insulin at the edge of foldability and its medical implications // PNAS. – 2020. – N 117 (47). – Р. 29618‒29628. https://doi.org/10.1073/pnas.2010908117
Prevention, management and better care of diabetes in the EU on the occasion of World Diabetes Day. European Parliament resolution of 23 November 2022 on prevention, management and better care of diabetes in the EU on the occasion of World Diabetes Day (2022/2901(RSP)) P9_TA(2022)0409
Resolution WHO 24 May 2021. Reducing the burden of noncommunicable diseases through strengthening prevention and control of diabetes. ‒ URL: https://apps.who.int/gb/ebwha/pdf_files/WHA74/A74_ACONF5-en.pdf
Vlasenko I. O., Davtian L. L. Standarty nalezhnoi aptechnoi praktyky yak bazys realizatsii kontseptsii farmatsevtychnoi dopomohy patsiientam iz tsukrovym diabetom // Farm. chasopys. – 2022. – № 1. – S. 74–82. https://doi.org/10.11603/2312-0967.2022.1.13058
Katangwe T., Family H., Sokhi J. et al. The community pharmacy setting for diabetes prevention: A mixed methods study in people with pre-diabetes // Research in Social and Administrative Pharmacy. – 2020. – N 16. – P. 1067–1080. https://doi.org/10.1016/j.sapharm.2019.11.001
Tkachenko N. O., Chervonenko N. M. Doslidzhennia okremykh aspektiv sanitarno-prosvitnytskoi diialnosti u farmatsii. ‒ URL: SCIENCE_AND_LIFE_N81_578-584.pdf
Bilai I. M., Mykhailiuk Ye. O. Farmatsevtychna opika ta komplaiens. Navch. posib. – Zaporizhzhia, 2016. – 77 s.
Boiko A. I. Kompiuterni tekhnolohii v optymizatsii likarskoho zabezpechennia khvorykh na tsukrovyi diabet // Novyny medytsyny ta farmatsii. – 2015. – № 12 (547). – S. 15.
Vlasenko I. O., Davtian L. L. Farmaevtychna dopomoha khvorym na tsukrovyi diabet shchodo zberihannia preparativ insulinu // Farmats. zhurn. – 2019. – T. 74, № 5. – S. 21–34. https://doi.org/10.32352/0367-3057.5.19.03
Bondar V. S. Metodolohichni osoblyvosti yakisnykh metodiv // Naukovi zapysky NaUKMA. – 2000. – T. 18 Sotsiolohichni nauky. – S. 31–34.
International Pharmaceutical Federation (FIP). Diabetes prevention, screening, and management: A handbook for pharmacists. – The Hague: FIP, 2021. – 67 p.
International Pharmaceutical Federation (FIP). Nutrition and weight management services: A toolkit for pharmacists. – The Hague: International Pharmaceutical Federation, 2021. – 82 p.
Centers for Disease Control and Prevention. Rx for the National Diabetes Prevention Program: Action Guide for Community Pharmacists. – Atlanta, GA: US Dept. of Health and Human Services, 2019.
Fornos-Pérez J., Andrés-Rodríguez N., Andrés-Iglesias J. еt al. Detection of people at risk of diabetes in community pharmacies of Pontevedra (Spain) // Endocrinología y Nutrición. – 2016. – V. 63, Iss. 8. – P. 387‒396. https://doi.org/10.1016/j.endonu.2016.06.002
Costa S., Horta M., Santos R. et al. Diabetes policies and pharmacy-based diabetes interventions in Portugal: a comprehensive review // J. Pharmac. Policy Practice. – 2019. – N 12. – P. 5. https://doi.org/10.1186/s40545-019-0166-1
Model of Integrated Care for Patients with Type 2 Diabetes. A Guide for Health Care Professionals. ‒ URL: https://www.hse.ie/eng/services/list/2/.pdf
Royal Pharmaceutical Society of GB. Practice Guidance on the Care of People with Diabetes. 3rd Edition. ‒ 2004. ‒ URL: http://faculty.ksu.edu.sa/hisham/Documents/Files_For_MS_Students/7.pdf
Cherniavska I. V. Otsinka mozhlyvosti rozvytku tsukrovoho diabetu pry riznomu rivni sertsevo-sudynoho ryzyku u cholovikiv // Int. J. Endocrinol. – 2015. – N 5 (69). ‒ URL: http://www.mif-ua.com/archive/article/41386
Budreiko O. A. Tsukrovyi diabet u ditei: problemni pytannia medychnoho suprovodu ta rol terapevtychnoho navchannia // Diabetolohiia, Tyreoidolohiia, Metabolichni rozlady. – 2016. – № 2 (34). – S. 48‒50.
Nakaz MOZ Ukrainy № 516/89 vid 19. 12. 2001. «Pro stvorennia systemy navchannia samokontroliu khvorykh na tsukrovyi diabet». – URL: https://zakon.rada.gov.ua/rada/show/v0516282-01#Text
Diabetes Strategy for Pharmacist. Canadian Pharmacists Association. – URL: http://www.pharmacists.ca/cpha-ca/assets/File/education-practice-resources/DiabetesPharmacistsOverviewEN.pdf
American Pharmacists Association. Certificate Training Programs. – URL: http://www.pharmacist.com/pharmacist--patient--centered--diabetes--care.
Shane-McWhorter L., Armor B., Johnson J. T. еt al. American Association of Diabetes Educators. – URL: https://www.diabeteseducator.org/docs/default-source/legacy-docs/_resources/pdf/PharmDScopeStandards.pdf
Eikenhorst L., Taxis K., Dijk L., Gier H. Pharmacist-Led Self-management Interventions to Improve Diabetes Outcomes. A Systematic Literature Review and Meta-Analysis // Frontiers. Pharmacology. – 2017. – N 8. – P. 891. https://doi.org/10.3389/fphar.2017.00891
Machen M., Borden H., Hohmeier K. The Impact of a Community Pharmacy Diabetes Self-Management Education Program on Diabetes Distress // J. Pharmacy Technol. – 2019. – V. 35, Iss. 1. – Р. 3‒10. https://doi.org/10.1177/8755122518805429
Rondy M., El Omeiri N., Thompson M. et al. Effectiveness of influenza vaccines in preventing severe influenza illness among adults: A systematic review and meta-analysis of test-negative design case-control studies // J. Infect. – 2017. – V. 75, Iss. 5. – Р. 381–394. https://doi.org/10.1016/j.jinf.2017.09.010
Goeijenbier M., van Sloten T. T., Slobbe L. et al. Benefits of flu vaccination for persons with diabetes mellitus: A review // Vaccine. – 2017. – N 35 (38). – Р. 5095–5101. https://doi.org/10.1016/j.vaccine.2017.07.095
International Diabetes Federation. IDF Europe Position Paper on the Vaccination of People living with Diabetes. ‒ 2021.
Vlasenko I. O., Davtian L. L. Okhoplennia vaktsynatsiieiu proty hrypu khvorykh na tsukrovyi diabet ta vyznachennia barieriv dlia yii provedennia // Farmats. zhurn. – 2022. – T. 77, № 6. – S. 22–32. https://doi.org/10.32352/0367-3057.6.22.03
FIP. Building vaccine confidence and communicating vaccine value: A toolkit for pharmacists. – 2021. – URL: https://www.fip.org/file/5093
FIP. Vaccination of special-risk groups: A toolkit for pharmacists. – 2022. – URL: https://www.fip.org/file/5380
Unifikovanyi klinichnyi protokol pervynnoi ta vtorynnoi (spetsializovanoi) medychnoi dopomohy tsukrovyi diabet 2 typu (nakaz MOZ Ukrainy vid 21. 12. 2012 r. № 1118). – URL: https://www.dec.gov.ua/wp-content/uploads/2019/11/2012_1118ykpmd.pdf
This work is licensed under a Creative Commons Attribution 4.0 International License.
